A Day Up For Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc. (MLND:NASDAQ) soared at $2.66, representing a gain of 34.3%. On Thu 28 May 20, MLND:NASDAQ hit a New 2-Week Intraday High of $2.17. The stock appeared on our News Catalysts scanner on Tue 19 May 20 at 06:23 PM in the 'BIOTECH' category. From Thu 14 May 20, the stock recorded 55.56% Up Days and 50.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Millendo Therapeutics, Inc. (MLND:NASDAQ)

OvaScience Inc is a biotechnology company focused on discovering, developing, and commercializing new fertility treatment options for women. The company's patented technology is based on a new fertility treatment option, "the newly discovered Egg precursor cells." Augment, the first treatment, is designed to improve egg health: Energy-producing mitochondria from a patient's own EggPC cells are added to the patient's mature eggs. The OvaPrime treatment is a fertility treatment that could allow a woman to increase her own egg reserve. The OvaTure treatment is a potential next-generation fertility treatment that could allow a woman produce healthy, young, fertilizable eggs without hormone injections.